Abstract
Aim: To evaluate demographics, treatment patterns, radiotherapy utilization and patient outcomes in meningeal melanocytomas. Materials & methods: The National Cancer Database was queried for meningeal melanocytomas diagnosed in 2002-2016. The effects of demographic, clinical and treatment variables were determined via Kaplan-Meier log-rank and Cox regression analyses. Results: The median and 5-year overall survival were 57.46 months and 48%, respectively. Patients earning ≥$48K showed improved survival (p = 0.0319). Radiotherapy and chemotherapy were utilized in 37.7 and 9% of patients, respectively. Conclusion: Income significantly affected survival. Surgery remains the mainstay approach. Radiotherapy was delivered in more than one-third of patients but did not impact survival. However, further analyses were limited by poor treatment modality information in the database.
Original language | English (US) |
---|---|
Pages (from-to) | 3243-3251 |
Number of pages | 9 |
Journal | Future Oncology |
Volume | 17 |
Issue number | 24 |
DOIs | |
State | Published - Aug 2021 |
Keywords
- Meningeal melanocytoma
- National Cancer Database
- Overall survival
- Patient income
- Spinal melanocytoma
ASJC Scopus subject areas
- Oncology
- Cancer Research